Ovid Therapeutics Inc. (NASDAQ:OVID) Receives Consensus Recommendation of “Buy” from Brokerages
Ovid Therapeutics Inc. (NASDAQ:OVID – Get Free Report) has been assigned a consensus recommendation of “Buy” from the seven brokerages that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the […]
Ovid Therapeutics Inc. (NASDAQ:OVID – Get Free Report) has been assigned a consensus recommendation of “Buy” from the seven brokerages that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the […]
